Structural analysis of botulinum neurotoxins type B and E by Cryo-EM

Sara Košenina; Markel Martínez-Carranza; Jonathan R. Davies; Geoffrey Masuyer; Pål Stenmark

doi:10.3390/toxins14010014

Structural analysis of botulinum neurotoxins type B and E by Cryo-EM

Sara Košenina, Markel Martínez-Carranza, Jonathan R. Davies, Geoffrey Masuyer, Pål Stenmark

Research output: Contribution to journal › Article › peer-review

9 Citations (SciVal)

Abstract

Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 Å for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular.

Original language	English
Article number	14
Journal	Toxins
Volume	14
Issue number	1
DOIs	https://doi.org/10.3390/toxins14010014
Publication status	Published - 23 Dec 2021

Bibliographical note

Funding Information:
Funding: This work was supported by grants from the Novo Nordisk Foundation (NNF20OC0064789), the Swedish Research Council (2018-03406) and the Swedish Cancer Society (20 1287 PjF) to P.S. G.M. was supported by a Research Fellowship from Applied Molecular Transport Inc. (San Francisco, CA, USA) at the University of Bath (UK). The data was collected at the Cryo-EM Swedish National Facility funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Umeå University.

Funding

Funding: This work was supported by grants from the Novo Nordisk Foundation (NNF20OC0064789), the Swedish Research Council (2018-03406) and the Swedish Cancer Society (20 1287 PjF) to P.S. G.M. was supported by a Research Fellowship from Applied Molecular Transport Inc. (San Francisco, CA, USA) at the University of Bath (UK). The data was collected at the Cryo-EM Swedish National Facility funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Umeå University. This work was supported by grants from the Novo Nordisk Foundation (NNF20OC0064789), the Swedish Research Council (2018-03406) and the Swedish Cancer Society (20 1287 PjF) to P.S. G.M. was supported by a Research Fellowship from Applied Molecular Transport Inc. (San Francisco, CA, USA) at the University of Bath (UK). The data was collected at the Cryo-EM Swedish National Facility funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Ume? University.

Keywords

BoNT/B
BoNT/E
Botulinum neurotoxin
Botulism
Clostridium botulinum
Cryo-EM

ASJC Scopus subject areas

Toxicology
Health, Toxicology and Mutagenesis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/toxins14010014Licence: CC BY

Cite this

@article{41a3e178108a444691e5ea600029b173,

title = "Structural analysis of botulinum neurotoxins type B and E by Cryo-EM",

abstract = "Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 {\AA} for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular.",

keywords = "BoNT/B, BoNT/E, Botulinum neurotoxin, Botulism, Clostridium botulinum, Cryo-EM",

author = "Sara Ko{\v s}enina and Markel Mart{\'i}nez-Carranza and Davies, {Jonathan R.} and Geoffrey Masuyer and P{\aa}l Stenmark",

note = "Funding Information: Funding: This work was supported by grants from the Novo Nordisk Foundation (NNF20OC0064789), the Swedish Research Council (2018-03406) and the Swedish Cancer Society (20 1287 PjF) to P.S. G.M. was supported by a Research Fellowship from Applied Molecular Transport Inc. (San Francisco, CA, USA) at the University of Bath (UK). The data was collected at the Cryo-EM Swedish National Facility funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Ume{\aa} University. ",

year = "2021",

month = dec,

day = "23",

doi = "10.3390/toxins14010014",

language = "English",

volume = "14",

journal = "Toxins ",

issn = "2072-6651",

publisher = "MDPI",

number = "1",

}

TY - JOUR

T1 - Structural analysis of botulinum neurotoxins type B and E by Cryo-EM

AU - Košenina, Sara

AU - Martínez-Carranza, Markel

AU - Davies, Jonathan R.

AU - Masuyer, Geoffrey

AU - Stenmark, Pål

N1 - Funding Information: Funding: This work was supported by grants from the Novo Nordisk Foundation (NNF20OC0064789), the Swedish Research Council (2018-03406) and the Swedish Cancer Society (20 1287 PjF) to P.S. G.M. was supported by a Research Fellowship from Applied Molecular Transport Inc. (San Francisco, CA, USA) at the University of Bath (UK). The data was collected at the Cryo-EM Swedish National Facility funded by the Knut and Alice Wallenberg, Family Erling Persson and Kempe Foundations, SciLifeLab, Stockholm University and Umeå University.

PY - 2021/12/23

Y1 - 2021/12/23

N2 - Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 Å for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular.

AB - Botulinum neurotoxins (BoNTs) are the causative agents of a potentially lethal paralytic disease targeting cholinergic nerve terminals. Multiple BoNT serotypes exist, with types A, B and E being the main cause of human botulism. Their extreme toxicity has been exploited for cosmetic and therapeutic uses to treat a wide range of neuromuscular disorders. Although naturally occurring BoNT types share a common end effect, their activity varies significantly based on the neuronal cell-surface receptors and intracellular SNARE substrates they target. These properties are the result of structural variations that have traditionally been studied using biophysical methods such as X-ray crystallography. Here, we determined the first structures of botulinum neurotoxins using single-particle cryogenic electron microscopy. The maps obtained at 3.6 and 3.7 Å for BoNT/B and /E, respectively, highlight the subtle structural dynamism between domains, and of the binding domain in particular. This study demonstrates how the recent advances made in the field of single-particle electron microscopy can be applied to bacterial toxins of clinical relevance and the botulinum neurotoxin family in particular.

KW - BoNT/B

KW - BoNT/E

KW - Botulinum neurotoxin

KW - Botulism

KW - Clostridium botulinum

KW - Cryo-EM

UR - http://www.scopus.com/inward/record.url?scp=85121826033&partnerID=8YFLogxK

U2 - 10.3390/toxins14010014

DO - 10.3390/toxins14010014

M3 - Article

AN - SCOPUS:85121826033

SN - 2072-6651

VL - 14

JO - Toxins

JF - Toxins

IS - 1

M1 - 14

ER -

Structural analysis of botulinum neurotoxins type B and E by Cryo-EM

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this